Also, MMP9, ELANE, NOTCH1, with fewer connected targets, have all been proven to have important regulatory effects in reducing liver lipid accumulation, inflammatory responses, fibrosis, and improving insulin resistance [22, 23]. The gene discussed is MMP9; the disease is Insulin resistance.